Arrowhead Pharmaceuticals, Inc. (ARWR)
NGS · Common · CUSIP 04280A100
Last Price•••.••
Current Yield•.••%
Yield to Call•.••%
Yield to Worst•.••%
Free registration unlocks the quote, yield calculations, price chart and full fundamentals for ARWR and every other security on QuantumOnline.
🔒
Price chart and 15 days of daily prices
Candlestick chart with moving averages, Bollinger bands and MACD. Register free to view.

Security Profile

Security Type
Common Stock
CUSIP
04280A100 (prev. 042797209 )
Market Cap
Large Cap
Previous Name
Arrowhead Research Corp.
Business: Arrowhead Pharmaceuticals, Inc. develops medicines that treat intractable diseases by silencing the genes that cause them. Using a broad portfolio of RNA chemistries and efficient modes of delivery, Arrowhead therapies trigger the RNA interference mechanism to induce rapid, deep, and durable knockdown of target genes.

Company Contact

CEO
Christopher Anzalone
CFO
Kenneth A. Myszkowski
Headquarters
177 E. Colorado Blvd, Suite 700, Pasadena, CA 91105
Phone
626-304-3400
Fax
626-304-3401
Investor Relations
Brian Ritchie, LifeSci Advisors, LLC · 212-915-2578 · britchie@lifesciadvisors.com
General Email
ir@arrowheadpharma.com
Email Form
Contact Form »
SEC EDGAR Filings
View filings »